جست‌وجوی استاد و پژوهشگر

Ariane Herrickمشاهده پروفایل

استاد

• Rheumatology
• Systemic Sclerosis
• Raynaud’s Phenomenon
• +۳ مورد دیگر

Professor Ariane Herrick is a Professor of Rheumatology at the University of Manchester, based in the Division of Musculoskeletal & Dermatological Sciences. She also serves as an Honorary Consultant Rheumatologist at Salford Royal NHS Foundation Trust. Her career spans over three decades with key appointments since 1993 (Consultant) and 2011 (Professor). Education: She earned her medical degree from the University of Aberdeen, followed by general medical training at Western Infirmary in Glasgow and specialized rheumatology training in Salford. Her professional memberships include the British Society for Rheumatology and the British Microcirculation Society. Research Interests: Her work focuses on systemic sclerosis-spectrum disorders and Raynaud’s phenomenon. She investigates vascular abnormalities using imaging techniques like nailfold capillaroscopy and explores novel treatments such as chelation therapies and low-level light therapy for calcinosis and digital ulcers. She leads clinical trials and collaborates with international groups like the SCTC and EUSTAR to advance diagnostic and therapeutic standards. Scientific Awards: A notable honor is her Fellowship of the Royal Society of Medicine (FRSM). Advising & Grants: As Principal Investigator, she oversees trials evaluating drug efficacy and imaging biomarkers. She has supervised 3 academic works, though specific student names are not disclosed. Her grants support innovations in microvascular assessment and patient-centered outcome measures. Labs/Teams: She collaborates with the UK Systemic Sclerosis Study Group, the Scleroderma Clinical Trials Consortium (SCTC), and the European Scleroderma Trials and Research Group (EUSTAR), contributing to large-scale observational studies like the European Scleroderma Observational Study (ESOS). Her research integrates clinical, imaging, and molecular approaches to address unmet needs in SSc management.

Ram Raj Singhمشاهده پروفایل

استاد

• Autoimmunity
• Rheumatology
• Immunology
• +۶ مورد دیگر

Ram Raj Singh is a Professor of Medicine and Pathology and Laboratory Medicine at the University of California Los Angeles (UCLA), where he maintains a dual appointment in the School of Medicine. His research spans multiple areas of immunology and autoimmune diseases, with particular focus on systemic sclerosis and lupus. Dr. Singh's research interests center on the immunological mechanisms underlying autoimmune diseases, particularly focusing on T-cell and B-cell biology in systemic sclerosis and lupus. His work explores the pathogenesis of autoimmune disorders, examining how innate and adaptive immune responses contribute to tissue damage and disease progression. His research has significant implications for understanding mortality patterns in autoimmune diseases and developing targeted therapies. Analysis of Dr. Singh's publication record reveals a strong focus on autoimmune disease epidemiology, particularly examining mortality trends in systemic sclerosis and lupus across different demographic groups. His research demonstrates expertise in both clinical and basic immunology, with publications spanning molecular mechanisms of disease to population-level health outcomes. A consistent theme throughout his work is the examination of how immune cell subsets (particularly T cells, B cells, and dendritic cells) contribute to autoimmune pathology. Dr. Singh has served as Principal Investigator on multiple NIH-funded research projects, including R01, R21, and T32 grants focused on autoimmune diseases. His research portfolio includes investigations into the pathogenesis of lupus dermatitis, gender bias in lupus, and the role of innate B1 B cells in lung hemorrhage. He has contributed significantly to understanding the immunological basis of autoimmune diseases and their clinical manifestations.

Belçin İzolمشاهده پروفایل

استادیار

• Dermatology
• Pediatric Dermatology
• Cosmetic Dermatology
• +۳ مورد دیگر

Dr. Belçin İzol serves as an Assistant Professor in the Department of Dermatology at Okan University Faculty of Medicine, a position she has held since October 2017. Previously, she was affiliated with Hospitalium Çamlıca Hospital and Kurtköy Ersoy Hospital (2011-2017) and began her academic career as teaching staff at Uludağ University Faculty of Medicine in 2010. Her educational journey includes: High School: Tarsus American College Medical Degree: Ankara University Faculty of Medicine (2001) Dermatology Specialty: S.B. Ankara Training and Research Hospital (2002-2008) Observership: Oregon Health and Science University Dermatologic Surgery-Cosmetic Dermatology and Pediatric Dermatology Clinic (2011) Dr. İzol's research demonstrates deep expertise across multiple dermatological domains. Her primary focus lies in pediatric dermatology , particularly morphea (localized scleroderma) in children, for which she published comprehensive epidemiological and clinical findings. In cosmetic dermatology , she has significantly contributed to understanding botulinum toxin applications and cellulite differential diagnosis. Her work in dermatologic surgery includes therapeutic innovations like pimecrolimus for rosacea. She has also investigated complex allergic conditions such as erythema multiforme-like contact dermatitis and autoimmune disorders including lichen planus with gastrointestinal correlations. Analysis of her publication history reveals a strong clinical orientation with emphasis on case documentation and observational studies. Her research consistently bridges dermatology with other specialties, exemplified by studies connecting lichen planus to H. pylori infection through endoscopic collaboration. She has explored therapeutic innovations for common conditions like acne and rosacea while maintaining focus on rare dermatological presentations, demonstrating both clinical acuity and scholarly rigor. No scientific awards were documented in the provided information. Details regarding student advising, grant funding, laboratory affiliations, or research teams were not specified in the source material.

David Leaderمشاهده پروفایل

دانشیار مدعو

• Evidence Based Dentistry
• Oral Health and Pregnancy
• Scleroderma and Oral Health
• +۳ مورد دیگر

David Leader is an Adjunct Associate Professor in the Department of Comprehensive Care at Tufts University School of Dental Medicine, with a secondary appointment in the School of Medicine's Public Health and Community Medicine department. He serves as the director of the dental emergency clinic and is a member of the Medical and Scientific Advisory Board for international scleroderma organizations. Master of Public Health, Tufts University School of Medicine, 2013 Doctorate of Dental Medicine, Tufts University School of Dental Medicine, 1985 Bachelor of Arts in History of Art, Emory University, 1981 His research focuses on evidence-based dentistry, oral health during pregnancy, and scleroderma-related oral health. Recent work explores systemic sclerosis interventions and chronic disease management through dental practice scope expansion. 2025: Oral health in systemic sclerosis scoping review 2021: Non-pharmacological interventions in systemic sclerosis 2019: Evidence-based dental practice improvement 2018: Dental roles in managing physician shortages Scientific honors include the 2017 Health Policy Fellowship, 2017 Tufts Provost's Teaching and Service Award, and the 2013 Delta Omega Poster Award. He chairs the Massachusetts Dental Society's Dental Education Committee. At Tufts, he teaches emergency dentistry and public health integration courses. He co-developed the 2016 Massachusetts Oral Health Guidelines for Pregnancy and Early Childhood and directs the DMD/MPH Dual Degree Program.

Vilja Pietiäinenمشاهده پروفایل

استاد مدعو

• Cancer Precision Medicine
• Functional Drug Testing
• Solid Tumor Research
• +۹ مورد دیگر

Vilja Pietiäinen is an Adjunct Professor and senior researcher at the Finnish Institute of Molecular Medicine (FIMM), University of Helsinki, specializing in Precision Systems Medicine. She serves as team leader in iCAN-Flagship projects including iCAN-PEDI/PREPAIR and DEDUCER, and acts as core director of FIMM High Content Imaging and Analysis (FIMM-HCA) within the HELMI platform. Her educational background includes a M.Sc. in clinical Biochemistry from the Faculty of Biosciences, University of Helsinki and University of Edinburgh, and a doctoral degree in Virology from the University of Helsinki. She holds a docentship in cellular and molecular biology from the University of Helsinki's Faculty of Biological and Environmental Sciences. Dr. Pietiäinen's research focuses on cancer precision medicine and functional drug testing of solid tumors. Her work involves isolating patient-derived cancer cells after surgery, growing them ex-vivo, and characterizing them using omics technologies including genomics, phenomics, and drug profiling. She develops microscopic imaging-based solutions for phenotyping and drug profiling of patient-derived cells, enabling better understanding of cellular heterogeneity in cancer and drug sensitivity and resistance in individual patients. Her research spans high-throughput screening, microscopy, cell biology, and intracellular trafficking. Her recent publications demonstrate strong focus on personalized cancer treatment approaches, with particular emphasis on pediatric solid tumors, renal cell carcinoma, and novel drug testing methodologies. The research shows integration of genomic analysis with functional drug testing to identify patient-specific treatment options, representing the cutting edge of precision oncology. Dr. Pietiäinen has extensive experience in research project leadership, having initiated the FIMM High Content Imaging and Analysis core unit in 2017. She has led projects with UPM on high-content 3D cell culture methods and served as project manager for the TEKES FiDiPro fellow project on image analysis solutions. She currently leads multiple active projects including FICAN South 2025, Syöpäsäätiö funding, and Academy of Finland infrastructure projects. She has significant teaching experience, having served as a teacher in laboratory courses, tutor for Problem Based Learning sessions for Medical Students, and lecturer at the University of Helsinki. She participates in course planning for the Medical Faculty, including Big Data and AI for clinical medicine, and contributes to curriculum development for the Master Program in Genetics and Molecular Biosciences. Currently, she serves as a part-time Coordinator of undergraduate education at FIMM.

Erika Lisabethمشاهده پروفایل

استادیار

• Drug Discovery
• Pharmacology
• Cancer Biology
• +۳ مورد دیگر

Erika Lisabeth, PhD, is an Assistant Professor (Fixed-Term) and Director of the Assay Development and Drug Repurposing Core (ADDRC) in the Department of Pharmacology & Toxicology at Michigan State University. She is affiliated with the College of Osteopathic Medicine and contributes to the MSU Drug Discovery initiative. Her work focuses on drug discovery targeting antifibrotic agents, proteasome enhancers, and Rho/MRTF pathway inhibitors. Education: BS in Chemistry, Michigan State University (1999—2023) PhD in Chemistry and Biochemistry, University of California, San Diego (2003—2009) Post-doctoral Training in Cancer Biology, Sanford Burnham Prebys Medical Discovery Institute (2009—2013) Research Interests: Development of novel antifibrotic compounds Mechanisms of Rho/MRTF/SRF-mediated gene transcription in cancer Targeting Eph receptor tyrosine kinases in lung cancer Optimization of drug delivery systems for fibrosis treatment Funding Highlights: National Institute of Neurological Disorders and Stroke (NINDS): Development of cellular HTS for 20S proteasome enhancers (2019–2022) Tobacco-Related Disease Research Program: Mapping the EphA Receptor Landscape in Lung Cancer (2011–2014) Lab Facilities: Assay Development and Drug Repurposing Core (ADDRC) Collaborations with the Pharmacology & Toxicology department's research infrastructure Teaching: PHM 801: Fundamental Principles of Pharmacology and Toxicology (Fall) PHM 803: Chemical Disposition in Mammals (Fall) PHM 805: Receptor Pharmacology (Fall)

Wei Weiمشاهده پروفایل

مدرس پاره‌وقت

• Asthma Research
• Genetic Epidemiology
• Bioinformatics
• +۳ مورد دیگر

Wei Wei is a Part-Time Lecturer at the University of Pittsburgh's Dietrich School of Arts and Sciences. Their research focuses on asthma epidemiology, genetic and epigenetic factors influencing respiratory diseases, and computational methods for analyzing high-dimensional biological data. Key areas of interest include asthma endotypes, gene-environment interactions, and the development of bioinformatics tools for precision medicine. Wei Wei collaborates on projects involving transcriptomic profiling of nasal and skin tissues, spatial transcriptomics for disease characterization, and machine learning approaches for predicting disease outcomes. Their work integrates multi-omics data to understand complex conditions such as asthma, cystic fibrosis, and systemic sclerosis. Notable contributions include studies on the impact of sociocultural stressors on asthma prevalence in Hispanic populations and the role of CD8+ T-cells in severe asthma pathogenesis. Publications span topics like environmental exposure effects, drug response biomarkers, and methodological advancements in epigenetic analysis. Wei Wei's research is supported by interdisciplinary collaborations within the university and external health initiatives.

• Fibrosis
• Tumorigenesis
• Scleroderma Pathogenesis
• +۳ مورد دیگر

Dr. Maria Trojanowska is a Professor at Boston University's Chobanian & Avedisian School of Medicine, specializing in Rheumatology. She leads the Arthritis & Autoimmune Diseases Research Center and holds affiliations with the BU-BMC Cancer Center, Pulmonary Center, and Evans Center for Interdisciplinary Biomedical Research. Her research focuses on molecular mechanisms underlying fibrosis and autoimmune diseases, particularly in systemic sclerosis (scleroderma). She investigates ECM synthesis regulation, vascular abnormalities, and tumor stroma activation. Dr. Trojanowska's work spans experimental models of fibrosis, ER stress in systemic sclerosis, and lymphatic vessel signaling. She has authored over 188 publications and secured NIH grants totaling millions in funding. Education: PhD from Polish Academy of Sciences, MSc from University of Warsaw. Her research interests include ECM dysregulation in fibrosis, vascular pathogenesis in scleroderma, and therapeutic targets like dimethyl fumarate. Recent studies explore ER stress and GATA6 signaling in pulmonary hypertension. Collaborations with Dr. Robert Lafyatis and others advance understanding of scleroderma pathophysiology. Dr. Trojanowska mentors graduate students and oversees grants on lymphatic ERG signaling, pulmonary arterial hypertension, and translational research in systemic sclerosis.

John Metcalfمشاهده پروفایل

استاد

• Dermatopathology
• Anatomic Pathology
• Clinical Pathology

John Metcalf is a Professor of Pathology at the Medical University of South Carolina College of Medicine, specializing in Dermatopathology , Anatomic Pathology , and Clinical Pathology . He is based in Charleston, SC, and his work focuses on complex dermatological conditions with a pathological lens. Education: Residency in Pathology-Anatomic and Clinical at Medical University of South Carolina (1974-1977) His research spans rare dermatological syndromes, immunotherapy-related pathologies, and genetic disorders with cutaneous manifestations. Publications highlight interdisciplinary approaches combining dermatology, pathology, and immunology. Recent work includes studies on nivolumab-induced scleroderma-like syndrome and cutaneous T-cell lymphoma in SHOC2 mutation-associated Noonan-like syndrome, reflecting his interest in atypical dermatopathological presentations.

Cinzia Anita Maria Progidaمشاهده پروفایل

استاد

• Cell Biology
• Molecular Biology
• Membrane Trafficking
• +۵ مورد دیگر

Cinzia Anita Maria Progida is a Professor in the Department of Biosciences at the University of Oslo, where she leads the Cell Dynamics research group within the Section for Physiology and Cell Biology (FYSCELL). Her laboratory is housed in the Institute of Biosciences building at Blindern campus in Oslo. Professor Progida's primary research focuses on understanding the molecular mechanisms underlying intracellular trafficking and the interplay between membrane transport and cytoskeleton dynamics. Her work particularly emphasizes the Rab family of small GTPases, which serve as master regulators of intracellular transport and also influence cytoskeleton remodeling. Her research group employs a combination of molecular and cell biology methods with state-of-the-art imaging techniques to unravel the spatio-temporal regulation of these cellular processes. An analysis of her recent publications reveals a consistent research trajectory centered on Rab GTPases and their roles in membrane trafficking, cell migration, and disease mechanisms. Her work spans fundamental cell biology to applications in cancer and immunology, with increasing emphasis on mechanobiology and the role of the endoplasmic reticulum in cellular processes. Recent publications demonstrate growing international collaboration with institutions across Europe and North America. Funding from Anders Jahres fond Funding from S. G. Sønneland Foundation Funding from Astri og Birger Torsteds legat Professor Progida actively mentors a diverse research team including current members Sathiaruby Sivaganesh, Marie Bergundhaugen, Jonathan Marcus Townson, and several others, along with numerous former lab members who have contributed to her extensive publication record. She has organized significant scientific events including the 'Cells on the Move' conference in 2016, demonstrating her leadership in the field of cell dynamics. Her laboratory maintains strong collaborations with institutions including Oslo University Hospital, Technical University of Denmark, Institute Curie in France, University of Salento in Italy, Leiden University in the Netherlands, and University of California Berkeley in the USA. Her research group 'Cell Dynamics - Progida' investigates how membrane traffic is regulated in eukaryotic cells and functions in concert with the cytoskeleton, with special emphasis on the molecular mechanisms controlling spatio-temporal dynamics and coordination between membrane traffic, cytoskeleton, and cell motility. They employ various imaging approaches, biochemistry, molecular and cell biology techniques to functionally characterize these processes.

Olga Yurievna Gorlovaمشاهده پروفایل

دانشیار

• Genetic epidemiology
• Lung cancer screening
• Genetics of Scleroderma
• +۱ مورد دیگر

Olga Yurievna Gorlova is an Associate Professor at Baylor College of Medicine, specializing in epidemiology and population science. Her research focuses on genetic epidemiology, lung cancer screening, scleroderma genetics, and graft versus host disease. Education Ph.D. in Genetics from the Institute of Cytology and Genetics, Novosibirsk, Russia Research Interests Dr. Gorlova's work centers on the intersection of genetics and public health, including: Population-based genetic risk modeling for lung cancer Genomic studies of scleroderma pathogenesis Immunogenetic analysis of transplant-related complications Development of preventive strategies through genetic screening

• Pediatric Rheumatology
• Immunology
• Precision Medicine
• +۳ مورد دیگر

Jessica Neely, MD is an Assistant Professor in the Department of Pediatrics at the University of California, San Francisco (UCSF) School of Medicine. She specializes in pediatric rheumatology, focusing on rare diseases like juvenile dermatomyositis. Her research utilizes single-cell genomic technologies to identify novel treatment targets and biomarkers for precision medicine. Education: MD from University of Kentucky College of Medicine (2013) Training: Pediatric Residency and Pediatric Rheumatology Fellowship at UCSF (2016–2019) Dr. Neely's research emphasizes understanding immune dysregulation mechanisms in juvenile dermatomyositis. She leads the Juvenile Myositis Precision Medicine (JuMP) Biorepository Center of Excellence and the I JuMP UP program, advancing rare disease care through collaborative initiatives. Her work bridges clinical care and translational research, aiming to improve outcomes for pediatric rheumatic conditions. Publications span topics like immune profiling in dermatomyositis, biomarker identification, and healthcare access barriers. Collaborations include leading investigators in rheumatology, immunology, and computational biology.

• Rheumatology
• Autoimmune Diseases
• Immunology
• +۱ مورد دیگر

Elizabeth Taylor-Albert is a part-time Clinical Assistant Professor of Medicine (Practitioner) at the University of Southern California. Her primary affiliation is with the Department of Medicine, where she focuses on clinical research and autoimmune disorders. Her contact email is etaylora@usc.edu. Her research explores autoimmune mechanisms, with emphasis on: Systemic Lupus Erythematosus (SLE) : Investigating autoantibody profiles in juvenile vs. adult populations Viral Etiology : Examining Epstein-Barr virus as a potential trigger for autoimmune responses Neonatal Manifestations : Studying cardiac complications like dilated cardiomyopathy in neonatal lupus Serological Markers : Characterizing anti-PM/Scl and ribosomal P autoantibodies in asymptomatic patients Her publications (1994-1999) demonstrate consistent focus on lupus pathogenesis, autoantibody behavior, and pediatric rheumatology. Research employs clinical case analyses, serological testing, and molecular cross-reactivity studies to advance diagnostic and therapeutic approaches.

Giuseppina Abignanoمشاهده پروفایل

عضو هیئت علمی

• Raynaud’s Phenomenon
• Systemic Sclerosis
• Fibrotic Diseases
• +۷ مورد دیگر

Dr. Giuseppina Abignano is a Visiting Research Fellow at the Leeds Institute of Rheumatic and Musculoskeletal Medicine (LIRMM) within the School of Medicine at the University of Leeds. She also holds the position of Clinical Researcher and Honorary Consultant in Rheumatology at the Rheumatology Institute of Lucania (IReL), Italy. Her work focuses on biomarker validation for rheumatic diseases, particularly Systemic Sclerosis and Psoriatic Disease, with expertise in imaging and serum biomarkers. Education: MD from the University of Naples (2006), Specialist Training in Rheumatology (2010), PhD in Immunology (2013), and Post-CCT Fellowship at Leeds Teaching Hospital NHS Trust (2015–2017). She was awarded Honorary Lecturer status at the University of Leeds in 2016. Research interests include skin imaging, validation of novel imaging techniques (e.g., Optical Coherence Tomography), and serum biomarker applications. She has contributed to international collaborations and presented work at major rheumatology congresses. Awards: Six notable awards, including recognition from the British Society for Rheumatology and the Italian Society of Rheumatology. Her research has been published in peer-reviewed journals and abstracts. Teaching and professional roles: Involved in medical undergraduate teaching at Leeds, core medical training, and peer-reviewing for high-impact journals. Collaborates with the scleroderma and psoriatic arthritis teams globally.

Andrea Murrayمشاهده پروفایل

مدرس ارشد

• Systemic Sclerosis
• Non-Invasive Imaging
• Microvascular Disease
• +۵ مورد دیگر

Andrea Murray is a Senior Lecturer at The University of Manchester, affiliated with the Division of Musculoskeletal & Dermatological Sciences and the Photon Science Institute (School of Physics and Astronomy). Her work is conducted at Salford Royal Hospital and focuses on non-invasive imaging techniques to study skin and blood vessel structure/function in systemic sclerosis. She holds a MPhys (Physics) and PhD (Physics) and completed a Versus Arthritis Career Development Fellowship (2011-2017). Research interests include light-tissue interaction, microvascular disease, and developing imaging methods to track disease progression. Her interdisciplinary approach involves collaborations with clinical and physics teams. Notable projects include piloting treatments for systemic sclerosis-related conditions and advancing capillaroscopy techniques. She is a member of professional bodies such as the British Microcirculation Society and European Society for Microcirculation. Recent work includes studies on capillaroscopy in COVID-19 patients and clinical trials for new treatments like vipoglanstat and C21. She has pioneered mobile health tools like the SALVE app for digital ulcer monitoring and conducted pilot studies using thermography for peripheral vascular assessment.